All News

A study finds rural and nonrural patients have similar follow-up times after positive stool-based DNA tests, supporting broader colorectal cancer screening access.

A 16-week Mediterranean diet reduced psoriasis severity and improved metabolic health in patients with mild to moderate psoriasis.

Three researchers received the 2025 Nobel Prize in Physiology or Medicine for discovering regulatory T cells and the Foxp3 gene, which revealed how the immune system prevents autoimmune disease.

Roflumilast cream 0.05% gains FDA approval for young children, offering a safe, effective treatment for mild to moderate atopic dermatitis.

Stephen Greene, MD, discusses the future and practical implications of optimizing quadruple foundational therapies for patients with heart failure.

Research highlights disparities in anti-obesity medication use and metabolic and bariatric surgery.

An epidemic resurgence is possible in Zambia should rapid restoration of HIV services not be conducted.

FDA approvals since the last Skin of Color Update expand topical and biologic options for various dermatological conditions, benefiting patients with skin of color.

Stronger partnerships between primary care and oncology improve patient outcomes by ensuring coordinated care and addressing financial and systemic barriers, says Mark Fendrick, MD.

The European Association for the Study of Obesity now recommends the 2 treatments for obesity and most associated complications.

The second dose of influenza vaccine was less effective overall when the studied cohort was expanded to any child younger than 9 years.

The FDA has approved a second generic version of oral mifepristone, used to terminate pregnancy, after determining it is identical to the branded drug.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Reducing data silos and boosting transparency in oncology requires payer-provider trust and co-governance, according to Vishnukamal Golla, MD, MPH.

Here are 5 reasons why bariatric surgery may be better for weight loss than GLP-1 receptor agonists

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

Lurbinectedin has been approved to be used in combination with atezolizumab or atezolizumab and hyaluronidase.

Five experts share their key takeaways from Patient-Centered Oncology Care® (PCOC) 2025, highlighting AI integration and collaboration to improve care.

Study finds slight temperature shifts are linked to changes in physiological stress responses.

Louisiana and Mississippi had the highest rates of maternal and child mortality in the country, respectively.

Programs such as Meds to Bed can work in tandem with retail pharmacies to offer accessible medications for patients.

Although overall costs have not declined with the Oncology Care Model (OCM), supportive care costs have decreased through greater use of cost-effective therapies.

An eHealth survey revealed widespread confusion, low awareness of 2026 Medicare plan changes, and growing interest in artificial intelligence support.

The US government shutdown could lead to telehealth, ambulance payment, and insurance cost disruptions.

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

The risk of pneumonia-related hospitalization increased the most for patients using non-TNFi biologics, climbing by 257% compared with controls.

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.

UC Davis pharmacy residents research medication management and patient care, focusing on how pharmacists improve outcomes and reduce readmissions, according to Jeremiah J. Duby, PharmD, BCPS, BCCCP.

The Trump administration advances the Most Favored Nation order by partnering with Pfizer, which came to the table voluntarily and has been granted a reprieve from upcoming drug tariffs.